Investment in the cell and gene therapy sector remains robust, despite the disruptions over the last several years due to the COVID-19 pandemic. That's one of the take-home messages from this week's Cell & Gene Meeting on the Mediterranean, according to ScienceBoard Vice President of Digital Media Sales Walt Schoenborn and reporter Melisande Rouger, who were on site in Barcelona, Spain.  

When you twist open an Oreo sandwich cookie, you're actually imitating a test of basic rheology that has implications for understanding and improving the texture of different food products. Lessons from analyzing the popular cookie could also be used to optimize foams, cosmetics, biological gels, screen printing, and viscoelastic inks used in 3D printing processes, according to research published on April 19 in AIP Physics of Fluids.  

Investment in the cell and gene therapy sector remains robust, despite the disruptions over the last several years due to the COVID-19 pandemic. That's one of the take-home messages from this week's Cell & Gene Meeting on the Mediterranean, according to ScienceBoard Vice President of Digital Media Sales Walt Schoenborn and reporter Melisande Rouger, who were on site in Barcelona, Spain.  

When you twist open an Oreo sandwich cookie, you're actually imitating a test of basic rheology that has implications for understanding and improving the texture of different food products. Lessons from analyzing the popular cookie could also be used to optimize foams, cosmetics, biological gels, screen printing, and viscoelastic inks used in 3D printing processes, according to research published on April 19 in AIP Physics of Fluids.  

Scitara is partnering with PerkinElmer on a new scientific integration platform that will grant scientists access to cross-functional data.  

Researchers at the U.S. National Institutes of Health（NIH）have bioengineered a "tissue chip" to show how a drug could potentially treat chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy. That data has been used by a Florida company to submit a U.S. Food and Drug Administration investigational new drug application.  

Bruker debuted new multiplex polymerase chain reaction（PCR）infectious disease assays and upgrades to its existing matrix-assisted laser desorption/ionization（MALDI）Biotyper platform at the annual European Congress of Clinical Microbiology and Infectious Diseases（ECCMIB）.